Clinical Trials Directory

Trials / Unknown

UnknownNCT06259864

Effects of Mollii Suit in Children With Non-Ambule Cerebral Palsy

Examining the Efficacy of Mollii Suit in Children With Non-Ambule Cerebral Palsy: A Single Blind Randomized Controlled Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Kırıkkale University · Academic / Other
Sex
All
Age
4 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to examine the effectiveness of the Mollii Suit application on gross motor function, spasticity, postural control, upper extremity skills, selective motor control, daily living activities, quality of life, pain, sleep, constipation and drooling problems in non-ambulatory individuals with cerebral palsy (CP).

Detailed description

Our study includes children diagnosed with spastic type cerebral palsy at GMFCS level 4 or 5 who applied to the Developmental Physiotherapy and Pediatric Rehabilitation Unit of Gazi University Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. After the patients are separated according to the specified exclusion and inclusion criteria, they will be divided into two groups by simple randomization method. Evaluations will be made before and after treatment. In addition to normal neurodevelopmental therapy (NGT) and Mollii Suit method will be applied 2 days a week. The total duration of treatment will take 8 weeks. Groups; The first group will consist of children with CP who will receive neurodevelopmental treatment. The second group will consist of children who will receive the Molli Suit method in addition to neurodevelopmental treatment.

Conditions

Interventions

TypeNameDescription
OTHEREXOPULSE Mollii Suit methodEXOPULSE Mollii Suit method, one of the newest rehabilitation technology products, is a non-invasive neuromodulation approach with a garment that covers the whole body and electrodes placed inside. Designed to improve motor function by reducing spasticity and pain, the method is based on the principle of reciprocal inhibition, which occurs by stimulating the antagonist of a spastic muscle at low frequencies and intensities.

Timeline

Start date
2024-01-20
Primary completion
2024-11-01
Completion
2024-12-30
First posted
2024-02-14
Last updated
2024-02-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06259864. Inclusion in this directory is not an endorsement.